DAFNA Capital Management as of Sept. 30, 2022
Portfolio Holdings for DAFNA Capital Management
DAFNA Capital Management holds 87 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Sp Biotech Etf Etf (XBI) | 12.1 | $45M | 566k | 79.32 | |
| Stereotaxis Com New (STXS) | 6.6 | $25M | 14M | 1.80 | |
| Blueprint Medicines (BPMC) | 4.6 | $17M | 261k | 65.89 | |
| Biohaven Pharmaceutical Holding | 4.5 | $17M | 110k | 151.17 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 3.8 | $14M | 136k | 103.26 | |
| Xenon Pharmaceuticals (XENE) | 3.6 | $14M | 375k | 36.10 | |
| Adicet Bio (ACET) | 3.6 | $13M | 936k | 14.22 | |
| Fate Therapeutics (FATE) | 3.3 | $12M | 540k | 22.41 | |
| Ishares Tr Nasdaq Biotech Indx Etf (IBB) | 3.2 | $12M | 103k | 116.96 | |
| Revolution Medicines (RVMD) | 2.5 | $9.5M | 480k | 19.72 | |
| Cytokinetics Com New (CYTK) | 2.4 | $8.9M | 184k | 48.45 | |
| Syndax Pharmaceuticals (SNDX) | 2.3 | $8.5M | 356k | 24.03 | |
| Neurocrine Biosciences (NBIX) | 2.3 | $8.5M | 80k | 106.21 | |
| Ideaya Biosciences (IDYA) | 2.2 | $8.0M | 539k | 14.92 | |
| Edgewise Therapeutics (EWTX) | 2.1 | $7.7M | 781k | 9.84 | |
| Nurix Therapeutics (NRIX) | 2.0 | $7.4M | 567k | 13.03 | |
| Iveric Bio | 1.9 | $7.2M | 402k | 17.94 | |
| Sage Therapeutics (SAGE) | 1.9 | $7.1M | 180k | 39.16 | |
| Karuna Therapeutics Ord | 1.7 | $6.5M | 29k | 224.92 | |
| Cymabay Therapeutics | 1.6 | $6.0M | 1.7M | 3.50 | |
| Dex (DXCM) | 1.6 | $5.8M | 73k | 80.54 | |
| Merus N V (MRUS) | 1.5 | $5.5M | 277k | 20.03 | |
| Morphic Hldg (MORF) | 1.5 | $5.5M | 196k | 28.30 | |
| Alector (ALEC) | 1.4 | $5.0M | 532k | 9.46 | |
| Mirati Therapeutics | 1.3 | $5.0M | 72k | 69.85 | |
| Century Therapeutics (IPSC) | 1.3 | $4.7M | 475k | 9.89 | |
| Arcus Biosciences Incorporated (RCUS) | 1.3 | $4.7M | 179k | 26.16 | |
| Aerie Pharmaceuticals | 1.3 | $4.6M | 307k | 15.13 | |
| Apellis Pharmaceuticals (APLS) | 1.2 | $4.5M | 66k | 68.30 | |
| Cardiovascular Systems | 1.1 | $4.0M | 287k | 13.86 | |
| Axogen (AXGN) | 1.1 | $4.0M | 332k | 11.92 | |
| 89bio (ETNB) | 1.0 | $3.8M | 655k | 5.79 | |
| Kalvista Pharmaceuticals (KALV) | 1.0 | $3.7M | 255k | 14.51 | |
| F-star Therapeutics | 0.8 | $3.0M | 577k | 5.12 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.8 | $2.8M | 122k | 23.26 | |
| Kura Oncology (KURA) | 0.8 | $2.8M | 206k | 13.66 | |
| AtriCure (ATRC) | 0.8 | $2.8M | 72k | 39.10 | |
| Mersana Therapeutics (MRSN) | 0.7 | $2.6M | 378k | 6.76 | |
| Mediwound Ord Shs | 0.5 | $2.0M | 1.4M | 1.39 | |
| Vigil Neuroscience (VIGL) | 0.5 | $2.0M | 216k | 9.10 | |
| Accuray Incorporated (ARAY) | 0.5 | $2.0M | 942k | 2.08 | |
| Iteos Therapeutics (ITOS) | 0.5 | $1.9M | 98k | 19.05 | |
| Larimar Therapeutics (LRMR) | 0.5 | $1.8M | 575k | 3.20 | |
| Galapagos Nv Spon Adr (GLPG) | 0.5 | $1.8M | 43k | 42.65 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.5 | $1.7M | 266k | 6.44 | |
| Dice Therapeutics | 0.4 | $1.6M | 79k | 20.28 | |
| Viking Therapeutics (VKTX) | 0.4 | $1.5M | 552k | 2.72 | |
| Aerie Pharmaceuticals Note 1.500%10/0 (Principal) | 0.4 | $1.5M | 1.5M | 0.98 | |
| Keros Therapeutics (KROS) | 0.4 | $1.5M | 39k | 37.62 | |
| Affimed Therapeutics B V | 0.4 | $1.4M | 686k | 2.06 | |
| Oric Pharmaceuticals (ORIC) | 0.4 | $1.3M | 414k | 3.20 | |
| Surface Oncology | 0.3 | $1.1M | 1.1M | 1.04 | |
| Autolus Therapeutics Spon Ads (AUTL) | 0.3 | $1.1M | 496k | 2.14 | |
| Neuronetics (STIM) | 0.3 | $998k | 314k | 3.18 | |
| Ngm Biopharmaceuticals | 0.3 | $980k | 75k | 13.07 | |
| Gamida Cell SHS | 0.3 | $978k | 615k | 1.59 | |
| Biohaven (BHVN) | 0.3 | $967k | 154k | 6.30 | |
| Scynexis Com New (SCYX) | 0.3 | $958k | 399k | 2.40 | |
| Regulus Therapeutics (RGLS) | 0.3 | $944k | 556k | 1.70 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.3 | $944k | 1.1M | 0.86 | |
| Kinnate Biopharma | 0.3 | $933k | 78k | 11.95 | |
| Pardes Biosciences | 0.2 | $887k | 479k | 1.85 | |
| Brainsway Sponsored Ads (BWAY) | 0.2 | $794k | 220k | 3.61 | |
| Genfit S A Ads (GNFT) | 0.2 | $686k | 188k | 3.65 | |
| Mei Pharma Com New | 0.2 | $683k | 1.8M | 0.39 | |
| Gh Research Ordinary Shares (GHRS) | 0.2 | $612k | 53k | 11.63 | |
| Medicenna Therapeutics Corp. (MDNAF) | 0.1 | $548k | 660k | 0.83 | |
| Black Diamond Therapeutics (BDTX) | 0.1 | $530k | 314k | 1.69 | |
| Nextcure (NXTC) | 0.1 | $516k | 188k | 2.75 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.1 | $508k | 47k | 10.72 | |
| Proqr Therapeutics Nv Shs Euro (PRQR) | 0.1 | $483k | 649k | 0.74 | |
| Theseus Pharmaceuticals | 0.1 | $475k | 82k | 5.80 | |
| Sutro Biopharma (STRO) | 0.1 | $451k | 81k | 5.55 | |
| Ikena Oncology (IKNA) | 0.1 | $435k | 123k | 3.55 | |
| Otonomy | 0.1 | $434k | 1.5M | 0.30 | |
| Compass Therapeutics (CMPX) | 0.1 | $429k | 188k | 2.28 | |
| Venus Concept | 0.1 | $426k | 968k | 0.44 | |
| Masimo Corporation (MASI) | 0.1 | $423k | 3.0k | 141.00 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $377k | 351k | 1.07 | |
| Inogen (INGN) | 0.1 | $364k | 15k | 24.27 | |
| Macrogenics (MGNX) | 0.1 | $346k | 100k | 3.46 | |
| Biomea Fusion (BMEA) | 0.1 | $339k | 35k | 9.79 | |
| Spero Therapeutics (SPRO) | 0.1 | $250k | 125k | 2.00 | |
| Lineage Cell Therapeutics In (LCTX) | 0.0 | $158k | 140k | 1.13 | |
| Reunion Neuroscience | 0.0 | $138k | 97k | 1.43 | |
| Compugen Ord (CGEN) | 0.0 | $135k | 205k | 0.66 | |
| Phasebio Pharmaceuticals | 0.0 | $57k | 322k | 0.18 |
